C4 Therapeutics, Inc.
CCCC
$2.61
-$0.08-2.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.48% | -24.94% | -18.76% | -16.69% | -3.46% |
| Total Receivables | -22.60% | -36.74% | 84.92% | -40.97% | -73.71% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.52% | 16.45% | -25.62% | 20.75% | 70.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 0.13% | -24.29% | -18.59% | -16.83% | -4.95% |
|
|
|||||
| Total Current Assets | 0.13% | -24.29% | -18.59% | -16.83% | -4.95% |
| Net Property, Plant & Equipment | -28.56% | -27.96% | -11.28% | -11.24% | -10.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.86% | -58.00% | -40.25% | -30.73% | -1.10% |
| Total Assets | 2.71% | -29.40% | -22.19% | -19.79% | -7.13% |
|
|
|||||
| Total Accounts Payable | -35.39% | -11.37% | 142.72% | -58.10% | -8.16% |
| Total Accrued Expenses | -31.88% | -29.87% | 34.41% | 0.04% | 12.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.27% | 10.37% | 10.43% | 10.53% | 10.63% |
| Total Finance Division Other Current Liabilities | -32.51% | -16.41% | -37.77% | -37.06% | -0.15% |
| Total Other Current Liabilities | -32.51% | -16.41% | -37.77% | -37.06% | -0.15% |
| Total Current Liabilities | -26.88% | -16.97% | -17.98% | -25.81% | 5.64% |
|
|
|||||
| Total Current Liabilities | -26.88% | -16.97% | -17.98% | -25.81% | 5.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.61% | -10.11% | -9.64% | -9.19% | -8.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -44.33% | -30.58% | 25.07% | 21.30% | 30.45% |
| Total Liabilities | -23.30% | -16.73% | -8.63% | -11.21% | 2.52% |
|
|
|||||
| Common Stock & APIC | 17.14% | 3.71% | 4.64% | 4.87% | 9.68% |
| Retained Earnings | -16.57% | -19.88% | -19.42% | -18.55% | -19.93% |
| Treasury Stock & Other | -5.66% | -80.88% | 93.18% | 111.32% | 141.73% |
| Total Common Equity | 18.80% | -36.37% | -29.55% | -24.45% | -12.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.80% | -36.37% | -29.55% | -24.45% | -12.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.80% | -36.37% | -29.55% | -24.45% | -12.24% |
|
|
|||||